<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Komorbiditeler &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/komorbiditeler/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 23 Dec 2025 19:15:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Komorbiditeler &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Comorbidities Shape Anaplastic Thyroid Cancer Treatment Outcomes</title>
		<link>https://bioengineer.org/comorbidities-shape-anaplastic-thyroid-cancer-treatment-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 23 Dec 2025 19:14:35 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Anaplastik tiroid kanseri]]></category>
		<category><![CDATA[Kişiselleştirilmiş Tıp]]></category>
		<category><![CDATA[Komorbiditeler]]></category>
		<category><![CDATA[Multidisipliner ekipler **Kısa Açıklama:** 1. **Anaplastik tiroid kanseri:** Makalenin temel konusu. 2. **Komorbiditeler:** Araştırmanın ana odağı ve tedavi sonuçlar]]></category>
		<category><![CDATA[Tedavi sonuçları]]></category>
		<guid isPermaLink="false">https://bioengineer.org/comorbidities-shape-anaplastic-thyroid-cancer-treatment-outcomes/</guid>

					<description><![CDATA[Anaplastic thyroid cancer (ATC) remains one of the most aggressive forms of thyroid malignancies, characterized by rapid progression and poor prognosis. Recent research by Augustin and colleagues has illuminated the significant impact of comorbidities on treatment management and prognosis for patients diagnosed with this formidable disease. ATC, although rare, poses severe challenges not only due [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">310703</post-id>	</item>
	</channel>
</rss>
